Skip to main content


Fig. 3 | Biology Direct

Fig. 3

From: Predicting survival times for neuroblastoma patients using RNA-seq expression profiles

Fig. 3

Kaplan-Meier estimates for HR and LPS2. Kaplan-Meier estimates for overall survival (left column) and event-free survival (right column) of clinically high risk patients using the gene annotation from the RNA-seq data. Rows 1-4 correspond to PLS, SPLS, lasso, and elnet fitting procedures. The orange line corresponds to patients labeled as LPS2 (predicted survival time less than 2 years), and blue lines are non-LPS2. The p-values are for the logrank test

Back to article page